CoreRx, founded in 2006, is a Contract Development Manufacturing Organization (CDMO) based out of Clearwater, FL. We offer state of the art facilities to support your supply chain needs throughout the entire drug development and commercialization process. Our comprehensive services include Pre-formulation (API characterization, excipient compatibility, stability etc.), formulation development, and clinical and commercial GMP manufacturing and analytical testing of solid, liquid, and semi-solid dosage forms.

Bend Bioscience, founded in 2021, is an early phase CDMO with an emphasis on product development and clinical manufacturing of enhanced formulations utilizing particle-engineering based drug delivery technologies such as spray drying. Building R&D partnerships to design and develop novel drug delivery platforms is a strategic component of Bend Bioscience’s offering, with the ambition to continue to enhance existing technologies and when necessary, evolve them to new technologies for unmet challenges.

CoreRx Summary:
-Founded in 2006 with Clearwater, Florida based campus
-Focused on oral solid, oral liquid, and topical dosage forms with broad formulation and manufacturing expertise
-World-class product development organization comprised of experienced formulators, chemists, and engineers
-Capabilities span pre-formulation, formulation development, analytical and stability testing, and GMP manufacturing 
-State-of-the-art purpose-built facilities with >150K sq. ft.
-Specialized capabilities include DEA schedule (II-V) and fit-for-purpose manufacturing suites
-Diverse customer base focused on non-sterile NBE, NCE and 505(b)2 programs with emphasis on small/virtual pharma
-Manufacturing 9 commercial products since first commercial launch in 2019

Bend Bioscience Summary:
-Founded in 2021, Bend, Oregon based campus
-Focused on oral drug product intermediate dosage forms with particle engineering expertise
-World-class product development organization comprised of experienced formulators, chemists, and engineers
-Capabilities span formulation development, analytical and stability testing, and GMP manufacturing
-State-of-the-art purpose-built facilities with ~30K sq. ft.
-Anticipated broad customer base focused on NBE and NCE programs including mid-size/large pharma